SAN DIEGO, March 20, 2017 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces a revised time for its presentation at the 27th Annual Oppenheimer Healthcare Conference. David Moskowitz, Vice President of Strategy and Corporate Communications, is now scheduled to present a corporate overview on Wednesday, March 22, 2017 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). The conference is being held at The Westin New York Grand Central in New York City.
A live webcast of the corporate presentation will be available on the Company's website at ir.biocept.com. A replay of the presentations will be available for 90 days.